EIF1AX and uveal melanoma: SF3B1 mutations are present in approximately 25% of malignant blue nevi and 15% of uveal melanomas while EIF1AX mutations are present in approximately 8% of malignant blue nevi and 24% of uveal melanomas [59,61].